Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-01

Clinical Trial Update: A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial in adults with Type 1 diabetes evaluated the pharmacokinetics, glucodynamics, and safety of BioChaperone Human Insulin, Huminsulin N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioChaperone Human Insulin
  • Humalog (insulin lispro)
  • Huminsulin Normal (insulin)

Snippet

Sponsor: Adocia | Conditions: Diabetes Mellitus Type 1 | Phase 1, Phase 2 | Status: COMPLETED